“We are extremely excited to expand our industry leading cancer characterization capabilities to the Huntsville area. Applied Genomics will add significant capabilities that fill a gap in our corporate offering. Clearly, having connectivity to the state of the art Hudson Alpha Institute and its genomic discovery capabilities was an attractive component in our search for the right development partner. We are enthusiastic about the short and long term opportunities of this deal.”
—Ron Andrews, chief executive officer, Clarient, Inc.